Sexual Health After Cancer: A Guide to Restoring Intimacy and Connection

October 3rd 2025, 1:00pm

By Gina Mauro

Kelly Dyckman discusses the mind-body connection during cancer care, offering tools for coping with diagnosis and intimacy struggles.

Remote Monitoring May Improve Recovery After Cancer Surgery

October 2nd 2025, 9:00pm

By Tracy Crane

FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer

October 2nd 2025, 8:05pm

By Alex Biese

The FDA has approved Zepzelca with Tecentriq or Tecentriq Hybreza for extensive-stage small cell lung cancer.

Lung Cancer Basics for Newly Diagnosed Patients

October 2nd 2025, 8:00pm

By Spencer Feldman

Lung cancer can be overwhelming, but learning about types, stages, treatments and support can help patients feel more prepared for their care journey.

How Lung Cancer Helped to Save My Life

October 2nd 2025, 5:00pm

By Sue McCarthy

Prior to my diagnosis with Stage 3B Lung Cancer, I had spent many years reading self-help books. I worked hard, but never felt successful, or took pride in myself.

September Blood Cancer Updates: What Patients Should Know

October 2nd 2025, 4:00pm

By Ryan Scott

Recent clinical trial results, real-world safety data, and patient experiences highlight meaningful advances in blood cancer care.

FDA Approves Guardant360 Test With Inluriyo for ESR1 Breast Cancer

October 2nd 2025, 3:00pm

By Spencer Feldman

The FDA approved Guardant360 CDx to identify adults with ESR1-mutated, ER-positive, HER2-negative breast cancer eligible for treatment with Inluriyo.

Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness

October 2nd 2025, 1:00pm

By Alison Ankiewicz

Alison Ankiewicz explains how pelvic physical therapy restores tissue, sexual function and emotional confidence for patients after cancer treatment.

Finding Strength and Advocacy During Breast Cancer Awareness Month

October 1st 2025, 9:00pm

By Ryan Scott

Jennie Smythe, a breast cancer survivor, shared her journey from diagnosis to survivorship in an interview with CURE during Breast Cancer Awareness Month.

Esophageal Cancer, From Diagnosis to Treatment

October 1st 2025, 8:00pm

By Alex Biese

A diagnosis of esophageal cancer can bring up many questions and concerns. Our goal is to provide you with clear, accurate and educational information.

All FDA Oncology Approvals From September 2025

October 1st 2025, 7:00pm

By Spencer Feldman

In September 2025, the FDA approved new treatments for breast, bladder and prostate cancers, plus biosimilars and a subcutaneous immunotherapy option.

Living with Lynch Syndrome

October 1st 2025, 5:00pm

By Georgia Hurst

Oct. 1, Previvor Day, acknowledges us who carry a hereditary cancer syndrome or genetic mutation that significantly increases our risk of cancer.

Twice-Daily Radiation Boosts Quality of Life in Small Cell Lung Cancer

October 1st 2025, 4:00pm

By Spencer Feldman

Adding Tecentriq to chemoradiation improved quality of life and supported twice-daily radiation for patients with limited-stage small cell lung cancer.

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

October 1st 2025, 3:00pm

By Ryan Scott

The FDA approved the denosumab biosimilars Enoby and Xtrenbo for patients on hormone therapies for breast or prostate cancer that weaken bones.

Understanding the Evolving Role of a Pathologist in Lung Cancer Care

October 1st 2025, 1:00pm

By Dr. Mary B. Beasley

Dr. Mary B. Beasley discusses evolving role of pathologists in lung cancer care, highlighting how emerging technologies may shape the future of the field.